Compare Stock Based Compensation To Revenue Across Equities
You can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible positions. Check out your portfolio center.
Cross Equities Stock Based Compensation To Revenue Analysis
Compare Cigna Corp, Definitive Healthcare, and Edwards Lifesciences Corp Stock Based Compensation To Revenue Over Time
Select Fundamental2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CI | 0.0034 | 0.0034 | 0.0034 | 0.0027 | 0.0029 | 0.0029 | 0.0032 | 0.0042 | 0.0037 | 0.0019 | 0.0018 | 0.0015 | 0.0015 | 0.0015 | 0.0029 |
DH | 0.0766 | 0.0766 | 0.0766 | 0.0766 | 0.0766 | 0.0766 | 0.0766 | 0.0766 | 0.0766 | 0.0766 | 0.0148 | 0.0599 | 0.1636 | 0.1939 | 0.2 |
EW | 0.0257 | 0.0209 | 0.0222 | 0.0232 | 0.0208 | 0.02 | 0.0192 | 0.0179 | 0.0191 | 0.0187 | 0.0211 | 0.0209 | 0.0236 | 0.0232 | 0.0237 |
GH | 0.0781 | 0.0781 | 0.0781 | 0.0781 | 0.0781 | 0.0781 | 0.0781 | 0.0736 | 0.0756 | 0.0791 | 0.5026 | 0.4053 | 0.2106 | 0.1609 | 0.16 |
LH | 0.0147 | 0.0088 | 0.0072 | 0.0064 | 0.0076 | 0.0118 | 0.0114 | 0.0105 | 0.0081 | 0.0093 | 0.008 | 0.0082 | 0.0079 | 0.0106 | 0.01 |
MD | 0.0147 | 0.0171 | 0.0157 | 0.0145 | 0.013 | 0.0116 | 0.0107 | 0.0086 | 0.0106 | 0.0101 | 0.0225 | 0.0099 | 0.0082 | 0.0062 | 0.0059 |
OM | 0.3926 | 0.3926 | 0.3926 | 0.3926 | 0.3926 | 0.3926 | 0.3926 | 0.3926 | 0.3926 | 0.0586 | 0.4293 | 0.17 | 0.2358 | 0.2963 | 0.29 |
DOCS | 0.0273 | 0.0273 | 0.0273 | 0.0273 | 0.0273 | 0.0273 | 0.0273 | 0.0273 | 0.0273 | 0.0202 | 0.0351 | 0.0915 | 0.1141 | 0.0998 | 0.0518 |
VEEV | 0.0058 | 0.0071 | 0.0055 | 0.0331 | 0.0457 | 0.0593 | 0.075 | 0.0788 | 0.0886 | 0.105 | 0.1263 | 0.1268 | 0.1633 | 0.1666 | 0.17 |
VERO | 0.0249 | 0.0249 | 0.0249 | 0.0249 | 0.0249 | 0.0249 | 0.0299 | 0.0218 | 0.0304 | 0.0195 | 0.0274 | 0.0196 | 0.0211 | 0.0205 | 0.0263 |
Cigna Corp, Definitive Healthcare, and Edwards Lifesciences Corp Stock Based Compensation To Revenue description
A metric that compares the total value of stock-based compensation granted by a company to its total revenue, indicating how much of the revenue is used to compensate employees with stock options or awards.Investing Ideas
You can quickly originate your optimal portfoio using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Thematic Opportunities
Explore Investment Opportunities
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |